AstraZeneca PLC (AZN) Stock Price

AZNStock

$162.70+0.55%52W

Market Cap$252.33B

P/E23.94x

PEG Ratio1.46

Div yield2.30%

Beta1.38

AZN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-33.83%

Price vs S&P 500 (4W)2.55%

PEG Ratio1.46

VGM Score52.10

P/E Ratio (Annual)23.94x

Indicated Dividend Yield (Annual)2.30%

P/CF (Annual)16.80x

Book Value / Share (Quarterly)$32.43

P/TBV (Annual)26.57x

Indicated Dividend (Annual)$236.20

Revenue Growth (3Y)9.82%

Cash Flow / Share (Quarterly)$3.90

Payout Ratio (TTM)46.93%

Price vs S&P 500 (YTD)-25.05%

Gross Margin (TTM)81.25%

Net Profit Margin (TTM)17.02%

EPS (TTM)$6.69

10-Day Avg Trading Volume1.66M

EPS Excl Extra (TTM)$6.69

Revenue Growth (5Y)17.15%

EPS (Annual)$6.55

Dividend / Share (Annual)$3.21

ROI (Annual)13.06%

Gross Margin (Annual)81.63%

Net Profit Margin (5Y Avg)10.23%

Cash / Share (Quarterly)$3.20

P/E Basic Excl Extra (TTM)23.44x

Revenue Growth QoQ (YoY)6.41%

EPS Growth (5Y)21.88%

P/E Normalized (Annual)23.94x

ROA (Last FY)8.96%

Revenue Growth TTM (YoY)8.61%

EBITD / Share (TTM)$11.69

ROE (5Y Avg)12.53%

Operating Margin (TTM)22.77%

Cash Flow / Share (Annual)$5.59

P/B Ratio4.87x

P/B Ratio (Quarterly)5.87x

Net Income / Employee (Annual)$106,400

EV / Revenue (TTM)4.44x

Net Interest Coverage (TTM)12.68x

ROA (TTM)9.12%

EPS Growth QoQ (YoY)2.27%

EV / EBITDA (TTM)14.91x

EPS Incl Extra (Annual)$6.55

Current Ratio (Annual)0.94x

Quick Ratio (Quarterly)0.67x

3-Month Avg Trading Volume1.74M

52-Week Price Return0.55%

EV / Free Cash Flow (Annual)31.39x

P/E Incl Extra (TTM)23.44x

Revenue / Employee (TTM)$638,600

Tangible BV / Share (Quarterly)$8.11

P/S Ratio (Annual)4.17x

Asset Turnover (Annual)0.51x

52-Week High$15730.00

Operating Margin (5Y Avg)14.21%

EPS Excl Extra (Annual)$6.55

CapEx CAGR (5Y)17.77%

Tangible BV CAGR (5Y)-2.48%

26-Week Price Return-21.90%

Quick Ratio (Annual)0.66x

13-Week Price Return-10.90%

Total Debt / Equity (Annual)0.61x

Current Ratio (Quarterly)0.89x

Enterprise Value$272.17B

Revenue / Share Growth (5Y)13.15%

Asset Turnover (TTM)0.54x

Book Value / Share Growth (5Y)21.40%

Revenue / Employee (Annual)$611,200

Inventory Turnover (Annual)1.82x

Pretax Margin (Annual)21.11%

Cash / Share (Annual)$3.70

3-Month Return Std Dev34.74%

Gross Margin (5Y Avg)80.23%

Net Income / Employee (TTM)$108,700

EBITDA CAGR (5Y)20.34%

EBITDA Interim CAGR (5Y)23.52%

ROE (Last FY)21.01%

Net Interest Coverage (Annual)10.09x

EPS Basic Excl Extra (Annual)$6.55

P/FCF (TTM)31.60x

Receivables Turnover (TTM)4.31x

EV / Free Cash Flow (TTM)45.03x

Total Debt / Equity (Quarterly)0.64x

EPS Incl Extra (TTM)$6.69

Receivables Turnover (Annual)5.67x

ROI (TTM)13.03%

Dividend Growth Rate (5Y)3.33%

P/S Ratio (TTM)3.99x

Pretax Margin (5Y Avg)11.43%

Revenue / Share (Annual)$37.60

Tangible BV / Share (Annual)$6.98

Forward P/E16.85x

Free OCF CAGR (5Y)31.64%

Price vs S&P 500 (52W)-18.00%

P/E Ratio (TTM)23.44x

EPS Growth TTM (YoY)25.92%

Year-to-Date Return-13.20%

5-Day Price Return-1.16%

EPS Normalized (Annual)$6.55

ROA (5Y Avg)5.03%

Net Profit Margin (Annual)17.41%

Month-to-Date Return-5.24%

Cash Flow / Share (TTM)$5.82

EBITD / Share (Annual)$11.41

EPS Growth (3Y)45.90%

Operating Margin (Annual)23.40%

LT Debt / Equity (Annual)0.51x

P/CF (TTM)17.87x

ROI (5Y Avg)7.37%

P/E Excl Extra (TTM)23.44x

LT Debt / Equity (Quarterly)0.47x

EPS Basic Excl Extra (TTM)$6.69

P/TBV (Quarterly)23.47x

Payout Ratio (Annual)48.62%

P/B Ratio (Annual)5.91x

Dividend / Share (TTM)$3.16

Inventory Turnover (TTM)1.72x

Pretax Margin (TTM)20.51%

Book Value / Share (Annual)$31.38

Price vs S&P 500 (13W)-12.85%

Net Margin Growth (5Y)7.71%

Dividend Yield (TTM)2.00%

Beta1.38x

P/FCF (Annual)28.24x

Revenue / Share (TTM)$39.34

ROE (TTM)21.74%

52-Week Low$10784.00

vGradeC

gGradeB

mGradeC

vgmGradeC

AZN Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 27, 2026	$1.25	$1.31	+4.85%(+$0.06)
Q1 2026	Apr 29, 2026	$1.27	$1.29	+1.43%(+$0.02)

AZN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.14

4.17

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
AZNAstraZeneca PLC	C	B	C	$162.70
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	C	C	B	$17.54

About AstraZeneca PLC

AstraZeneca is a multinational pharmaceutical company formed in 1999 through the merger of Sweden's Astra and UK-based Zeneca. The company develops and markets branded drugs across oncology (over 40% of revenue), cardiovascular and metabolic diseases (20%+), rare diseases, and respiratory and immunology. Its revenue is geographically diversified, with approximately one-third of sales derived from the United States and the remainder from international markets.